Perioperative management of intracranial aneurysm and subarachnoid hemorrhage

Ehab Farag*, Zeyd Ebrahim, David Traul, Irene Katzan, Edward Manno

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Stroke is the third leading cause of death and the leading cause of disability in contemporary society. Aneurysmal subarachnoid hemorrhage (aSAH) is a hemorrhagic stroke which accounts for 7% of all stroke cases and 22 to 25% of cerebrovascular deaths. Aneurysmal subarachnoid hemorrhage is a very complex disease and many controversies on its pathophysiology and management have not yet been settled. The aim of this review is to present the most recent evidence-based advances in the pathophysiology and perioperative management of aSAH.

Original languageEnglish (US)
Pages (from-to)5792-5808
Number of pages17
JournalCurrent Pharmaceutical Design
Volume19
Issue number32
DOIs
StatePublished - Oct 1 2013

Keywords

  • Delayed neurologic deficits
  • Stroke
  • Subarachnoid hemorrhage
  • Vasospasm

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Perioperative management of intracranial aneurysm and subarachnoid hemorrhage'. Together they form a unique fingerprint.

Cite this